Promising LOX proteins for cartilage-targeting osteoarthritis therapy

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease causing pain and mobility loss.
• LOX proteins, encompassing three families, significantly influence cartilage homeostasis and OA progression.
• Current treatments for OA lack disease-modifying capabilities, highlighting the need for novel therapeutic targets.

Purpose of the Study:

• To clarify the distinct roles of various LOX protein families in osteoarthritis.
• To review potential therapeutic strategies targeting LOX proteins for OA drug development.
• To explore intraarticular delivery methods for advanced OA therapy.

Main Methods:

• Literature review of studies on LOX proteins and osteoarthritis.
• Analysis of the involvement of lipoxygenase, lectin-like oxidized low-density lipoprotein, and lysyl oxidase families in OA.
• Identification and discussion of potential drug targets and inhibition strategies.

Main Results:

• Lipoxygenase enzymes contribute to OA inflammation via pro-inflammatory leukotrienes.
• Lectin-like oxidized low-density lipoprotein receptors activate catabolic pathways in chondrocytes.
• Lysyl oxidase and lysyl oxidase-like enzymes are crucial for cartilage extracellular matrix integrity.

Conclusions:

• Lysyl oxidase-like 2 emerges as a key target for disease-modifying OA therapies.
• Targeting LOX proteins presents a promising avenue for developing novel OA treatments.
• Intraarticular drug delivery strategies are being considered for localized OA therapy.